Trial Profile
A Study of the Efficacy and Safety of Multiple Doses of Dutasteride Versus Placebo and Finasteride in the Treatment of Male Subjects With Androgenetic Alopecia
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 05 Sep 2023
Price :
$35
*
At a glance
- Drugs Dutasteride (Primary) ; Finasteride
- Indications Alopecia
- Focus Therapeutic Use
- Sponsors GlaxoSmithKline; GSK
- 06 Nov 2015 New trial record